-
Taletrectinib vs Entrectinib in ROS1-Positive (ROS1+) Non-Small Cell Lung Cancer (NSCLC): A Matching-Adjusted Indirect Comparison (MAIC)
Mar 10, 2025, 14:00 PM -
Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)
Mar 10, 2025, 14:00 PM -
Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data
Mar 10, 2025, 14:00 PM -
Measurement of Short-Term Functional Outcome Using Modified Rankin Scale in Patients With Acute Ischaemic Stroke
Mar 10, 2025, 14:00 PM -
Cost Savings With Treosulfan and Fludarabine (Treo/Flu) vs. Busulfan and Fludarabine (Bu2/Flu) Conditioning Regimen in Patients Undergoing Allogeneic HSCT for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insights From a Real-World Retrospective Study
Mar 10, 2025, 14:00 PM -
Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data
Mar 10, 2025, 14:00 PM -
Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions
Mar 10, 2025, 14:00 PM -
Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV
Mar 10, 2025, 14:00 PM -
Is Poor Adherence to Good Modeling Practices Making Us Worry Too Much About Effect Modifiers? A Case Study in Moderate to Severe Plaque Psoriasis
Mar 10, 2025, 14:00 PM -
Obesity Impact on Incidence of Chronic Comorbid Conditions
Mar 10, 2025, 14:00 PM -
Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards
Mar 10, 2025, 14:00 PM -
The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis
Mar 10, 2025, 14:00 PM -
Evaluation of a Novel Approach to Deduplication of Trial Registry Records in Systematic Reviews
Mar 10, 2025, 14:00 PM -
Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs
Mar 10, 2025, 14:00 PM -
Real-World Patient Characteristics and Treatment Patterns in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Long-Term Survivorship
Mar 10, 2025, 14:00 PM -
A Critical Review of Existing Shared Decision-Making Measuring Approaches in Studies Using the Medical Expenditure Panel Survey (MEPS)
Mar 10, 2025, 14:00 PM -
Evaluating Attributes of Non-Oncology Orphan Approvals From 2015-2024
Mar 10, 2025, 14:00 PM -
Could Offering Physiotherapy Services in Emergency Departments Improve Patients’ Quality of Life While Reducing Healthcare Costs?
Mar 10, 2025, 14:00 PM -
Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)
Mar 10, 2025, 14:00 PM
